Metropolitan Life Insurance Company (MetLife)’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,678
Closed -$1.62M 485
2024
Q1
$1.62M Sell
6,678
-107
-2% -$24.6K 0.07% 241
2023
Q4
$1.39M Sell
6,785
-112
-2% -$21.9K 0.07% 261
2023
Q3
$1.24M Sell
6,897
-161
-2% -$29.7K 0.06% 262
2023
Q2
$1.36M Sell
7,058
-179
-2% -$31K 0.07% 261
2023
Q1
$1.16M Sell
7,237
-2,129
-23% -$338K 0.06% 294
2022
Q4
$1.55M Buy
9,366
+112
+1% +$17.7K 0.07% 270
2022
Q3
$1.25M Buy
9,254
+172
+2% +$24.7K 0.06% 299
2022
Q2
$1.28M Sell
9,082
-210
-2% -$32.1K 0.06% 312
2022
Q1
$1.44M Sell
9,292
-7,784
-46% -$1.1M 0.05% 330
2021
Q4
$2.27M Sell
17,076
-497
-3% -$61.1K 0.03% 461
2021
Q3
$2.1M Sell
17,573
-388
-2% -$46.6K 0.03% 476
2021
Q2
$2.06M Sell
17,961
-3,876
-18% -$458K 0.03% 516
2021
Q1
$2.58M Sell
21,837
-1,147
-5% -$124K 0.04% 406
2020
Q4
$2.25M Sell
22,984
-1,065
-4% -$107K 0.03% 435
2020
Q3
$2.33M Sell
24,049
-1,190
-5% -$118K 0.04% 375
2020
Q2
$2.54M Sell
25,239
-4,283
-15% -$394K 0.05% 335
2020
Q1
$2.61M Sell
29,522
-639
-2% -$56.3K 0.05% 300
2019
Q4
$2.56M Sell
30,161
-387
-1% -$33.2K 0.04% 413
2019
Q3
$2.52M Sell
30,548
-504
-2% -$43.3K 0.04% 394
2019
Q2
$2.65M Buy
31,052
+1,139
+4% +$90.1K 0.04% 376
2019
Q1
$2.38M Sell
29,913
-1,146
-4% -$92.1K 0.04% 400
2018
Q4
$2.31M Sell
31,059
-555
-2% -$47.8K 0.05% 354
2018
Q3
$2.92M Sell
31,614
-1,235
-4% -$107K 0.05% 332
2018
Q2
$2.8M Buy
32,849
+339
+1% +$29.8K 0.05% 348
2018
Q1
$2.8M Buy
32,510
+295
+0.9% +$28.3K 0.04% 354
2017
Q4
$2.96M Sell
32,215
-51,905
-62% -$4.29M 0.04% 341
2017
Q3
$6.96M Sell
84,120
-3,207
-4% -$272K 0.04% 380
2017
Q2
$8.26M Sell
87,327
-1,457
-2% -$130K 0.06% 315
2017
Q1
$7.86M Sell
88,784
-2,301
-3% -$202K 0.05% 344
2016
Q4
$7.12M Sell
91,085
-9,051
-9% -$706K 0.05% 372
2016
Q3
$8.09M Sell
100,136
-2,543
-2% -$218K 0.06% 303
2016
Q2
$8.14M Sell
102,679
-8,810
-8% -$707K 0.06% 302
2016
Q1
$9.65M Sell
111,489
-1,572
-1% -$140K 0.07% 254
2015
Q4
$11.7M Sell
113,061
-7,489
-6% -$735K 0.09% 220
2015
Q3
$11.5M Sell
120,550
-3,767
-3% -$395K 0.08% 226
2015
Q2
$13.2M Buy
124,317
+509
+0.4% +$57.3K 0.09% 207
2015
Q1
$14.1M Sell
123,808
-1,078
-0.9% -$108K 0.1% 199
2014
Q4
$11.3M Sell
124,886
-4,950
-4% -$424K 0.08% 256
2014
Q3
$10M Sell
129,836
-8,969
-6% -$682K 0.07% 262
2014
Q2
$10.1M Sell
138,805
-8,716
-6% -$597K 0.07% 274
2014
Q1
$9.68M Sell
147,521
-2,675
-2% -$182K 0.07% 290
2013
Q4
$10.6M Sell
150,196
-5,071
-3% -$341K 0.07% 262
2013
Q3
$9.49M Sell
155,267
-1,149
-0.7% -$67.2K 0.07% 278
2013
Q2
$8.73M Buy
+156,416
New +$8.49M 0.07% 286

Other funds holding COR

Metropolitan Life Insurance Company (MetLife)'s COR Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cencora (COR) in Q2 2024, closing a stake of 6,678 shares — an estimated $1.62M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in COR in Q2 2013 and held it in 44 quarters. The position peaked at $14.1M in Q1 2015. 1,134 funds tracked by Wall St. Rank hold COR as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Cencora position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,678 Cencora shares in Q2 2024, an estimated $1.62M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Cencora in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Cencora position peaked at $14.1M in Q1 2015.
  • 1,134 funds tracked by Wall St. Rank held Cencora as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.